Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Abstract
Intravesical Bacillus Calmette–Guerin (BCG) immunotherapy is a proven, effective treatment for intermediate- and high-risk non-muscle-invasive bladder cancer. Minor side effects are common and expected but systemic effects can occur in < 5% of treated patients. We present a rare case of a 49-year-old male that presented with fever and chills after 3 weeks of intravesical BCG therapy post transurethral resection of bladder tumor. New renal lesions were present on contrast-enhanced computed tomography scan which was histologically proven to be necrotizing renal granulomatosis.
Document Type
Article
Publication Date
4-18-2018
Digital Object Identifier (DOI)
https://doi.org/10.4103/2156-7514.230280
Repository Citation
Tran-Harding, Karen; Nair, Rashmi T.; and Ganesh, Halemane S., "Renal Granulomatosis Post Intravesical Bacillus Calmette-Guerin Therapy for Non-Muscle-Invasive Bladder Cancer" (2018). Radiology Faculty Publications. 14.
https://uknowledge.uky.edu/radiology_facpub/14
Included in
Bioimaging and Biomedical Optics Commons, Diagnosis Commons, Oncology Commons, Radiology Commons, Urology Commons
Notes/Citation Information
Published in Journal of Clinical Imaging Science, v. 8, 18, p. 1-4.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.